Ajinomoto And Astellas Pharma Inc. Jointly File Application Seeking Additional Approval For Combination Therapy Of FASTIC/STARSIS Tablets

Published: Jan 31, 2006

Tokyo, Jan 31, 2006 (JCN) - Ajinomoto and Astellas Pharma jointly announced on January 27 that they have filed a supplemental New Drug Application (SNDA) for FASTIC Tablet/STARSIS Tablet (nateglinide), a fast-acting postprandial hypoglycemic agent co-developed by the two companies.

Back to news